Literature DB >> 6297508

Collagenase and collagenolytic activity in human osteoarthritic cartilage.

J P Pelletier, J Martel-Pelletier, D S Howell, L Ghandur-Mnaymneh, J E Enis, J F Woessner.   

Abstract

Forty-nine specimens of human cartilage were taken from 3 sites on the tibial plateau (center of osteoarthritic lesion, edge of lesion, and remote site) and graded histologically by the scale of Mankin. The tissue was homogenized and centrifuged to obtain an insoluble pellet. This was resuspended in buffer and incubated at 37 degrees C, pH 7.5. Collagen digestion was quantitated by the release of hydroxyproline-containing peptides. The highest collagenolytic activity (4.6%) was found in the center of lesions, declining in remote sites to 2.4% and in controls to 1.1%. Moderately severe disease of grade 6--9 had the highest collagenolytic activity. Approximately 55% of the metal-dependent collagenolytic activity was in a latent form, activatable by amino-phenylmercuric acetate; the remainder was self-active. A method was developed for the extraction of collagenase from cartilage; the extracted enzyme produced the typical 75:25 cleavage products of type I collagen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297508     DOI: 10.1002/art.1780260110

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  36 in total

1.  Concerning the ultrastructural origin of large-scale swelling in articular cartilage.

Authors:  M H Chen; N D Broom
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

2.  Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage.

Authors:  E Vignon; A Martin; P Mathieu; T Conrozier; P Louisot; M Richard
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Interleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.

Authors:  R D Pasternak; S J Hubbs; R G Caccese; R L Marks; J M Conaty; G DiPasquale
Journal:  Agents Actions       Date:  1987-08

Review 4.  Anatomy and pathophysiology of the sacroiliac joint.

Authors:  O Calvillo; I Skaribas; J Turnipseed
Journal:  Curr Rev Pain       Date:  2000

5.  N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage.

Authors:  P Loulakis; A Shrikhande; G Davis; C A Maniglia
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

6.  Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage.

Authors:  J P Pelletier; J Martel-Pelletier
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

8.  Chondrogenic cells respond to partial-thickness defects of articular cartilage in adult rats: an in vivo study.

Authors:  Kaibin Zhang; Jing Shi; Yang Li; Yiqiu Jiang; Tianqi Tao; Wang Li; Jianchao Gui
Journal:  J Mol Histol       Date:  2016-03-08       Impact factor: 2.611

9.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

Authors:  M Mohtai; R L Smith; D J Schurman; Y Tsuji; F M Torti; N I Hutchinson; W G Stetler-Stevenson; G I Goldberg
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.